Two drugs going through clinical trials. One for mesothelioma and one for melanoma. Very impressive for a small and fairly unknown penny stock. If either one of these is successful then you're talking potential buyout candidate by a big pharmaceutical in my opinion. Most new drugs don't even make it into phase 1 studies. The preliminary efficacy studies kill a lot of the drugs before they reach phase 1.